Literature DB >> 21115345

Isolated dysphagia due to paraneoplastic myasthenic syndrome with anti-P/Q-type voltage-gated calcium-channel and anti-acetylcholine receptor antibodies.

Roberto Fernandez-Torron1, Juan Arcocha, Jose M López-Picazo, Javier Pardo, Maria Akiko Tamura, Cristina Carretero, Pau Pastor.   

Abstract

Dysphagia is a common symptom in neuromuscular junction disorders, but it rarely occurs in isolation or is the presenting feature. We describe a patient presenting with isolated dysphagia to liquids. Electrophysiological studies, such as repetitive nerve stimulation and single-fiber electromyography, were normal. Serum anti-P/Q-type voltage-gated calcium-channel (anti-P/Q-type VGCC) and anti-acetylcholine receptor (AChR ab) antibodies were above the normal range. A computed tomography scan showed a mediastinal mass corresponding to a thymic carcinoma. After chemotherapy, surgical removal of the thymic carcinoma and radiotherapy, the patient no longer complained of dysphagia, AChR ab titers were reduced and anti-P/Q-type VGCC antibodies became negative. To the best of our knowledge, no previous reports of a paraneoplastic myasthenic syndrome related to thymic carcinoma with both anti-P/Q-type VGCC and AChR antibodies have been described. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115345     DOI: 10.1016/j.nmd.2010.10.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.

Authors:  Ran-Ran Zhang; Tao Han; Fang Guo; Zhao-Zhe Liu; Ya-Ling Han; Wei-Chi Chen; Yong-Ye Liu; Xiao-Dong Xie
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

Review 2.  The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma.

Authors:  Sarah Ew Briggs; Paul Gozzard; Denis C Talbot
Journal:  Immunotargets Ther       Date:  2013-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.